Noriko Ogawa
Overview
Explore the profile of Noriko Ogawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuninaka H, Usumoto Y, Tanabe M, Ogawa N, Mukai M, Nasu A, et al.
Leg Med (Tokyo)
. 2025 Feb;
:102591.
PMID: 39893060
No abstract available.
2.
Kurumazaki M, Ogawa N, Kobayashi M, Ikejiri F, Kanasaki K
Intern Med
. 2025 Jan;
PMID: 39814384
We herein report a 56-year-old man with severe hypocalcemia during ruxolitinib therapy for myelofibrosis transitioning from JAK2 mutation-positive polycythemia vera. Blood transfusions were administered every one to two weeks for...
3.
Ogawa N, Yamamoto M, Kobayashi R, Kawamura A, Matsumoto A, Otani H, et al.
J Bone Miner Metab
. 2025 Jan;
PMID: 39806228
Introduction: Despite many studies on the prevalence of vertebral fractures (VFs), the VF prevalence at death in the Japanese population remains unclear. Materials And Methods: We evaluated the VF prevalence...
4.
5.
Oyama S, Ogawa N, Yasunaga T, Yamamoto H
Chem Pharm Bull (Tokyo)
. 2024 Dec;
72(12):1073-1083.
PMID: 39710376
A co-amorphous state composed of probucol (PC) and fluvastatin sodium salt (FLU) was prepared by spray-drying (SD). We have previously reported that PC and atorvastatin calcium trihydrate salt (ATO) formed...
6.
Yasunaga T, Fukuoka T, Yamaguchi A, Ogawa N, Yamamoto H
Int J Pharm
. 2024 Oct;
666:124810.
PMID: 39395547
Microtaggant technologies for on-dose authentication have garnered significant interest for use in the anti-counterfeit activities and traceability of pharmaceutical dosage forms. Previously, we proposed a stealth nanobeacon (NB) comprising self-assembled...
7.
Oyama S, Ogawa N, Kawai K, Iwai K, Yasunaga T, Yamamoto H
Chem Pharm Bull (Tokyo)
. 2024 Feb;
72(2):190-199.
PMID: 38369345
A co-amorphous model drug was prepared by the spray-drying (SD) of probucol (PC) and atorvastatin calcium trihydrate salt (ATO) as low water solubility and co-former components, respectively. The physicochemical properties...
8.
Kuninaka H, Usumoto Y, Tanabe M, Ogawa N, Mukai M, Nasu A, et al.
Leg Med (Tokyo)
. 2023 Dec;
66:102358.
PMID: 38056179
Spinal cord injury is difficult to detect directly on postmortem computed tomography (PMCT) and it is usually diagnosed by indirect findings such as a hematoma in the spinal canal. However,...
9.
Ogawa N, Yomota M, Notsu M, Kanasaki K
Cureus
. 2023 Sep;
15(8):e43950.
PMID: 37746349
We treated a 36-year-old man with thymic hyperplasia complicated with Graves' disease. Thymic hyperplasia was observed on thoracic computed tomography (CT) three months after the onset of thyrotoxicosis symptoms. One...
10.
Yasunaga T, Fukuoka T, Yamaguchi A, Ogawa N, Yamamoto H
Yakugaku Zasshi
. 2022 Nov;
142(11):1255-1265.
PMID: 36328452
The globalization of drug trade has led to the increased production of falsified medicines. In addition, poor medication adherence increases the costs of healthcare. The need to manage medication has...